北京时间2019年06月17日22时40分,Anthera制药(ANTH.us)股票出现波动,股价快速下跌14.29%。截至发稿,该股报0.054美元\/股,成交量1340股,换手率0.01%,振幅0.16%。
最新的2018-03-31数据显示,该股实现营业收入0.00美元,净利润-7.72百万美元,每股收益-0.42美元,毛利-161000.00美元,市盈率-0.04倍。
机构评级方面,目前暂无机构对该股做出“买入、持有、卖出”建议。
Anthera制药股票所在的生物技术行业中,整体涨幅为1.80%。其相关个股中,Array生物制药、Contravir Pharmaceuticals Inc、Verastem Oncology涨幅较大,Contravir Pharmaceuticals Inc、Dare Bioscience Inc、Sellas Life Sciences Group Inc较为活跃,换手率分别为595.58%、41.96%、37.68%,振幅较大的相关个股有Contravir Pharmaceuticals Inc、Histogenics Corp、Verastem Oncology,振幅分别为50.51%、29.40%、25.36%。
Anthera制药公司简介:Anthera Pharmaceuticals Inc is a biopharmaceutical company that focuses on developing and commercializing products to treat serious diseases associated with inflammation, including cardiovascular and autoimmune diseases. The company currently has one Phase 3-ready clinical program and two Phase 2 clinical programs. It was established in 2004.
(以上内容为自选股智能机器写手Money Call完成,仅作为用户看盘参考,不作为交易依据。)
热门推荐
收起24小时滚动播报最新的财经资讯和视频,更多粉丝福利扫描二维码关注(sinafinance)